阿司匹林对减少尿毒症患者内瘘血栓形成的效果  

Aspirin on reducing fistula thrombosis in patients with uremic

作　　者：方梅荣 潘红霞[1] 董建华[1] 李鎛江 董艳[1] 张帆[1] 肖友文[1] Fang Meirong;Pan Hongxia;Dong Jianhua;Li Bojiang;Dong Yan;Zhang Fan;XiaoYouwen(The People＇s Hospital of LeshanCity（Sichuan）614000)

机构地区：[1]乐山市人民医院,四川614000

出　　处：《中国社区医师》2018年第29期26-27,共2页Chinese Community Doctors

摘　　要：目的:探讨阿司匹林对减少尿毒症患者内瘘血栓形成的效果。方法:收治尿毒症患者80例,对照组采用常规肝素抗凝治疗,观察组在此基础上联合阿司匹林治疗。结果:观察组有内瘘血栓形成1例,对照组内瘘血栓形成9例(P<0.05);观察组中内瘘闭塞丧失功能1例,对照组7例(P<0.05);观察组凝血酶原时间明显短于对照组(P<0.05)。结论:在尿毒症患者的临床治疗中应用阿司匹林,能够有效预防内瘘血栓。Objective：To investigate the effect of aspirin on reducing internal fistula thrombosis in uremic patients.Methods：80patients with uremia were treated with routine heparin anticoagulation,while the observation group was treated with aspirin.Results：There was 1 case of internal fistula thrombosis in the observation group,and 9 cases of thrombus formation in the control group（P〈0.05）,1 caseloss function of internal fistula occlusion in the observation group and 7 cases in the control group（P〈0.05）, and the prothrombin time in the observation group was significantly shorter than that of the control group（P〈0.05）.Conclusion： Application of aspirin in the treatment of uremic patients can effectively prevent internal fistula thrombosis.

关 键 词：尿毒症 阿司匹林 内瘘血栓 临床效果 

分 类 号：R692.5[医药卫生—泌尿科学]